how early intervention impacts long-term survival in patients with mf
Published 2 years ago • 193 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
2:28
investigating the impact of pacritinib on survival in patients with mf and severe thrombocytopenia
-
2:08
real-world analysis of the most study: factors impacting progression to mf in patients with et
-
1:58
current barriers to early intervention in myelofibrosis
-
2:19
maintaining remission in aml and improving long-term survival in patients who do not receive hsct
-
1:20
the impact of early ruxolitinib treatment on os in the comfort-i and comfort-ii studies
-
1:34
the importance of early intervention and closing the equity gap in scd
-
1:10
canakinumab in preventing progression of high-risk ccus to myeloid neoplasms: a phase ii study
-
0:49
extending survival in patients with cll: novel agents, mrd, and overcoming rt
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
2:41
israeli company on the edge of finding diabetes cure
-
1:46:07
hematology lecture
-
2:20
the effect of ibrutinib dose-reduction on outcomes of patients with cll/sll: real-world evidence
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
3:29
ibrutinib in previously untreated high-risk smoldering mcl: insights from a phase ii trial
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:41
an overview of the latest advances in hematology
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:03
the importance of the mdt in managing transplant survivors
-
1:01
advancements in cml: improving treatment-free remission and novel agents
-
1:11
genetic dynamics and factors predictive of survival in relapsed aml